ADRB2 and Parkinson disease: In the neurotoxin-based model of PD, one group suggested that β2-AR signaling regulates mouse α-SYN expression leading to neuroprotection [16], while a different group suggest that β2-AR signaling directly reduced microglial activation [18, 35].